NEPH vs XLI
Nephros Inc (NEPH) versus XLI (XLI) — a side-by-side from cached financials, not a winner call.
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
XLI (XLI) common stock.
Latest reported NEPH revenue for 2026-06-30 was $11.2M. Net income was $1.3M. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
XLI does not have a complete income-statement cache yet.
NEPH currently screens at market cap $40.9M and trailing P/E 48.3. XLI currently screens at market cap $0.
Not investment advice. Open the NEPH and XLI stock pages for the full models.
Not investment advice.